XM does not provide services to residents of the United States of America.

Wall St muted as hot PPI keeps smaller rate cut in view; Moderna slumps



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall St muted as hot PPI keeps smaller rate cut in view; Moderna slumps</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window

August producer prices slightly above estimates

Moderna tumbles after dour FY25 revenue forecast

Kroger gains after results

Indexes: Dow down 0.1%, S&P 500 flat, Nasdaq up 0.1%

Updated at 09:45 a.m. ET

By Shashwat Chauhan and Lisa Pauline Mattackal

Sept 12 (Reuters) -Wall Street was little changed on Thursday after hot producer prices data kept a smaller 25-basis point interest rate cut by the Federal Reserve firmly on the table, while vaccine maker Moderna's shares slumped following a downbeat revenue forecast.

The producer price index (PPI) for final demand rose 0.2% in August, compared with estimates of 0.1% growth. The core number, which strips out volatile food and energy prices, rose 0.3%, higher than the 0.2% forecast.

"Headline PPI inflation came in as expected, but the core rate followed the consumer's (consumer price index) core rate almost to the tee, a little bit more than expected," said Peter Cardillo, chief market economist at Spartan Capital Securities.

"If you look at today's PPI numbers it just confirms the Fed is not going to be as aggressive in cutting rates as the market was expecting."

Separately, initial claims for state unemployment benefits stood at 230,000 for the week ended Sept. 7, in line with estimates.

Meanwhile, Moderna's MRNA.O shares dropped 17.8% to their lowest intraday level since November. They were the biggest decliner on the S&P 500 after the company forecast sales between $2.5 billion and $3.5 billion next year, below analysts' estimates.

A string of weakening employment and economic growth data over the past few weeks had led to rising bets on a larger-than-usual 50-bps interest rate reduction from the U.S. central bank, but those expectations have largely faded.

Following Thursday's data and the inflation report in the previous session, traders now see an 85% chance of the Fed cutting interest rates by 25 bps when it meets on Sept. 17-18, according to CME's FedWatch Tool. It would be the first rate cut since March 2020.

"Our base case forecast looks for a 25 bps reduction in the federal funds rate at the September FOMC meeting followed by two 50 bps rate cuts at the November and December FOMC meetings," analysts at Wells Fargo said.

The Dow Jones Industrial Average .DJI fell 41.40 points, or 0.10%, to 40,820.31, the S&P 500 .SPX gained 0.10 point to 5,554.23, and the Nasdaq Composite .IXIC gained 24.42 points, or 0.14%, to 17,419.95.

The information technology index .SPLRCT pulled back after a 3.2% jump on Wednesday, falling 0.3%, while the healthcare sector .SPXHC also fell 0.3%.

An index tracking semiconductor shares .SOX dropped 0.7%, led by a more than 5% fall in Micron Technology MU.O after a report that Exane BNP Paribas downgraded the chipmaker's shares to "underperform" from "outperform."

The more economically sensitive small-cap Russell 2000 .RUT meanwhile outperformed, rising 0.5%.

Among other stocks, Kroger KR.N gained 3% after the supermarket chain beat estimates for second-quarter results and raised the lower end of its annual sales forecast.

Chemicals maker Dow DOW.N slipped 0.7% after lowering its third-quarter revenue forecast due to an unplanned event at one of its plants in Texas.

Advancing issues outnumbered decliners for a 2.01-to-1 ratio on the NYSE and a 1.39-to-1 ratio on the Nasdaq.

The S&P 500 posted 22 new 52-week highs and no new low, while the Nasdaq Composite recorded 35 new highs and 27 new lows.



Reporting by Shashwat Chauhan and Lisa Mattackal in Bengaluru; Editing by Maju Samuel and Shounak Dasgupta

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.